These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 26342945

  • 21. Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats.
    Zhang J, Ren CX, Qi YF, Lou LX, Chen L, Zhang LK, Wang X, Tang C.
    Life Sci; 2006 Aug 15; 79(12):1153-9. PubMed ID: 16674982
    [Abstract] [Full Text] [Related]

  • 22. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients.
    El-Shehaby AM, El-Khatib MM, Battah AA, Roshdy AR.
    Scand J Clin Lab Invest; 2010 Oct 15; 70(6):421-7. PubMed ID: 20645679
    [Abstract] [Full Text] [Related]

  • 23. Transcardiac gradients of circulating apelin: extraction by normal hearts vs. release by hearts failing due to pressure overload.
    Helske S, Kovanen PT, Lommi J, Turto H, Kupari M.
    J Appl Physiol (1985); 2010 Dec 15; 109(6):1744-8. PubMed ID: 20864562
    [Abstract] [Full Text] [Related]

  • 24. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M.
    J Hypertens; 2007 Apr 15; 25(4):833-9. PubMed ID: 17351376
    [Abstract] [Full Text] [Related]

  • 25. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
    Pouleur AC, Uno H, Prescott MF, Desai A, Appelbaum E, Lukashevich V, Smith BA, Dahlöf B, Solomon SD, ALLAY Investigators.
    J Renin Angiotensin Aldosterone Syst; 2011 Dec 15; 12(4):483-90. PubMed ID: 21746765
    [Abstract] [Full Text] [Related]

  • 26. A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy.
    Matsumura N, Robertson IM, Hamza SM, Soltys CM, Sung MM, Masson G, Beker DL, Dyck JR.
    Am J Physiol Heart Circ Physiol; 2017 Mar 01; 312(3):H561-H570. PubMed ID: 28062414
    [Abstract] [Full Text] [Related]

  • 27. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B, Güneri S, Badak O, Aslan O, Tamci B.
    Anadolu Kardiyol Derg; 2002 Jun 01; 2(2):121-9; AXVII. PubMed ID: 12134537
    [Abstract] [Full Text] [Related]

  • 28. Serum soluble RAGE level inversely correlates with left ventricular hypertrophy in essential hypertension patients.
    Liu Q, Chen HB, Luo M, Zheng H.
    Genet Mol Res; 2016 Jul 14; 15(2):. PubMed ID: 27421025
    [Abstract] [Full Text] [Related]

  • 29. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M, Cicala S, De Simone L, Caso P, Petrocelli A, Pietropaolo L, Celentano A, Mininni N, de Divitiis O.
    Ital Heart J; 2001 Sep 14; 2(9):677-84. PubMed ID: 11666096
    [Abstract] [Full Text] [Related]

  • 30. [Effects of puerarin on expression of apelin and its receptor of 2K1C renal hypertension rats].
    Jin G, Yang P, Gong Y, Fan X, Tang J, Lin J.
    Zhongguo Zhong Yao Za Zhi; 2009 Dec 14; 34(24):3263-7. PubMed ID: 20353015
    [Abstract] [Full Text] [Related]

  • 31. Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients.
    Shen A, Hou X, Yang D, Liu T, Zheng D, Deng L, Zhou T.
    Medicine (Baltimore); 2014 Dec 14; 93(29):e154. PubMed ID: 25546658
    [Abstract] [Full Text] [Related]

  • 32. Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients.
    Farcaş AD, Anton FP, Goidescu CM, Gavrilă IL, Vida-Simiti LA, Stoia MA.
    Dis Markers; 2017 Dec 14; 2017():2714095. PubMed ID: 28566800
    [Abstract] [Full Text] [Related]

  • 33. Association between left ventricular hypertrophy with retinopathy and renal dysfunction in patients with essential hypertension.
    Shirafkan A, Motahari M, Mojerlou M, Rezghi Z, Behnampour N, Gholamrezanezhad A.
    Singapore Med J; 2009 Dec 14; 50(12):1177-83. PubMed ID: 20087555
    [Abstract] [Full Text] [Related]

  • 34. Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension.
    Siciliano M, Mettimano M, Dondolini-Poli A, Ballarin S, Migneco A, Annese R, Fazzari L, Fedeli P, Montebelli MR, Zuppi C, Savi L.
    Ital Heart J; 2000 Aug 14; 1(8):532-5. PubMed ID: 10994933
    [Abstract] [Full Text] [Related]

  • 35. Endogenous regulation of cardiovascular function by apelin-APJ.
    Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T.
    Am J Physiol Heart Circ Physiol; 2009 Nov 14; 297(5):H1904-13. PubMed ID: 19767528
    [Abstract] [Full Text] [Related]

  • 36. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y, Damle A.
    Curr Med Res Opin; 2004 May 14; 20(5):639-44. PubMed ID: 15140328
    [Abstract] [Full Text] [Related]

  • 37. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
    Kleinz MJ, Skepper JN, Davenport AP.
    Regul Pept; 2005 Mar 30; 126(3):233-40. PubMed ID: 15664671
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies.
    Cuspidi C, Sala C, Negri F, Mancia G, Morganti A, Italian Society of Hypertension.
    J Hum Hypertens; 2012 Jun 30; 26(6):343-9. PubMed ID: 22113443
    [Abstract] [Full Text] [Related]

  • 39. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
    Kozakova M, Paterni M, Bartolomucci F, Morizzo C, Rossi G, Galetta F, Palombo C.
    Am J Hypertens; 2007 Mar 30; 20(3):279-84. PubMed ID: 17324740
    [Abstract] [Full Text] [Related]

  • 40. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.
    Engle SK, Solter PF, Credille KM, Bull CM, Adams S, Berna MJ, Schultze AE, Rothstein EC, Cockman MD, Pritt ML, Liu H, Lu Y, Chiang AY, Watson DE.
    Toxicol Sci; 2010 Apr 30; 114(2):183-92. PubMed ID: 20044590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.